A review of plasma exchange in sepsis

Blood Purification

Volumn 20, Issue 3, 2002, Pages 282-288

  Reeves, John H ^a  

^a EPWORTH HOSPITAL   (Australia)

Author keywords

Cytokines; Extracorporeal therapy; Inflammation; Outcome; Plasma filtration

Indexed keywords

ALPHA 1 ANTITRYPSIN; FRESH FROZEN PLASMA; GLOBULIN; GRANULOCYTE COLONY STIMULATING FACTOR; HAPTOGLOBIN; HUMAN ALBUMIN; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

CENTRIFUGATION; CLINICAL TRIAL; CONFERENCE PAPER; DISSEMINATED INTRAVASCULAR CLOTTING; EXCHANGE BLOOD TRANSFUSION; EXTRACORPOREAL CIRCULATION; HEMODYNAMICS; HEMOFILTRATION; HUMAN; MENINGOCOCCEMIA; MORTALITY; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SEPTICEMIA; SURVIVAL RATE; TREATMENT OUTCOME; ULTRAFILTRATION;

ANIMALS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; PLASMA EXCHANGE; SEPSIS; TREATMENT OUTCOME;

EID: 0036187357     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047021     Document Type: Conference Paper

References (55)

1. Increase in National Hospital Discharge Survey rates for septicaemia - United States 1979-1987
2. Prospective study of the treatment of septic shock
3. Pathogenetic mechanisms of septic shock
4. Immunologic therapy for ARDS, septic shock, and multiple-organ failure
5. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis
6. A controlled trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
7. Introduction of new technology into critical care practice: A history of HA-1A human monoclonal antibody against endotoxin
8. A second large scale controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicentre, randomised, controlled trial
9. INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
10. Assessment of the safety and efficycy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study
11. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial
12. Platelet activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomised, double blind, placebo-controlled multi-center clinical trial
13. Efficacy and safety of recombinant human activated protein C for severe sepsis
14. Plasmapheresis in severe sepsis or septic shock
15. Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome
16. Analaysis of membrane processes for blood purification
17. Continuous plasmafiltration in sepsis syndrome
18. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure
19. Circulating cytokines: The tip of the iceberg?
20. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury
21. Plasma exchange morbidity in Guillain-Barré syndrome: Results from the French prospective, randomized, multicenter study
22. Albumin controversy continues. Meta-analysis has affected use of albumin
23. Hazards of apheresis
24. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis
25. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes
26. Nosocomial Neisseria meningitidis sepsis as a complication of plasmapheresis
27. Exchange transfusion with citrated whole blood for disseminated in-travascular coagulation
28. Plasmapheresis for menigococcaemia with disseminated intravascular coagulation
29. Role of exchange transfusion in the treatment of severe septicemia
30. Sclerema neonatorum
31. Endotoxin clearance by exchange transfusion in septic shock neonates
32. Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange
33. Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients
34. Plasmapheresis for streptococcal sepsis?
35. Is there a role for plasmapheresis/exchange transfusion in the treatment of the septic burn patient?
36. Plasmapheresis for fulminant meningococcemia
37. Detection of circulating tumor necrosis factor after endotoxin administration
38. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
39. Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion
40. Plasma and whole blood exchange in meningococcal sepsis
41. Blood filtration in children with severe sepsis: Safe adjunctive therapy
42. Hemodynamic effects of plasma exchange in septic patients: Preliminary report
43. Plasma exchange therapy for endotoxin shock in puppies
44. Protection from endotoxemia: A rat model of plasmapheresis and specific adsorption with polymyxin B
45. Continuous plasma filtration coupled with sorbents
46. On-line plasma exchange for sepsis in neonates and infants
47. Plasma exchange does not improve survival in a canine model of human septic shock
48. Plasma exchange performed during severe gram negative septicaemia: The influence on circulatory performance, plasma levels of endotoxin and bacterial counts in the blood
49. The treatment of severe gram negative septicemia with plasma exchange: Effects mediated by extracorporeal recirculation
50. The influence of plasma exchange on shock mediators in septicemia
51. Repeated plasma therapy induces fatal shock in experimental septicemia
52. Blood purification for critical care medicine: Endotoxin adsorption
53. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption
54. Continuous plasma filtration coupled with sorbents
55. Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock